Abstract
Osteonecrosis of the jaws associated with bisphosphonate therapy is characterized as an area of avascular necrosis with an evolution time greater than 8 weeks and without previous history of head and neck radiation. We contribute 2 well-documented new cases of osteonecrosis that affected a male patient and a female patient with a history of oncology therapy using intravenous zolendronate. Lesions were symptomatic and infected bone exposure in the maxilla had a duration of more than 8 weeks, 1 postexodontia and the other 1 post–spontaneous tooth avulsion. The female patient had a good response to the antibiotic therapy and is currently kept under control without pain. The male patient that continued bisphosphonate therapy had a poor prognosis with expansion of bone exposure and spontaneous avulsion of other teeth.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
